Enthera
Enthera is an IGFBP3 Inhibitors - Monoclonal Antibody, Fusion Proteins founded in 2016.
2
Funding Rounds
$43.5m
Money raised
Overview
Enthera is an IGFBP3 Inhibitors - Monoclonal Antibody, Fusion Proteins founded in 2016.
- Websites:
- Headquarters: Milan
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Enthera has raised a total of $8.5m in funding over 2 rounds.
Key Insights:
- Enthera January 2021 Series A Funding Round: $8.5m
- Enthera Series A round January 2021: $35m
Enthera January 2021 Series A Funding Round
$8.5m
Enthera Series A round January 2021
$35m
Industries
Enthera is active in the following industries: